Pronađeno: 1-10 / 88 radova

Autori: Andric Zoran G

>> Filter: Samo Article i Review

Naslov Real-world treatment patterns in patients with human epidermal growth factor receptor 2 (HER2) - positive early breast cancer in Serbia and Montenegro - HEReNA (Meeting Abstract)
Autori Bozovic-Spasojevic Ivana M  Milovic-Kovacevic Marijana M  Lekic S  Cvetanovic A  Kolarov-Bjelobrk Ivana N  Lucic J  Andric Zoran G  Milenkovic D  ...  Vukovic I  Petronijevic M  Calamac Marina  Djurmez Ognjen  Djuric S  Perduv V  Radisavljevic M  Popovic Lazar S 
Info BREAST, (2025), vol. 80 br. , Suppl. S, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Reply to P. de Boissieu et al (Letter)
Autori Spigel David R  ...  Chen Yuanbin  Navarro Alejandro  Chih Hsin Yang James  Stojanovic Goran  Jove Maria  ...  Andric Zoran G  ...  (broj koautora 17) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2025), vol. 43 br. 3, str. -
Projekat Ipsen
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov 3-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer (Meeting Abstract)
Autori Verschraegen C  Andric Zoran G  Moiseenko FV  Makharadze T  Oleksiienko A  Ruiz EP Yanez  Kim SH  Ahn K  Park TH  Ju HA  Baek EH  Kwon S  Lee SJ  Chang I  Kim SH  Kim HA  Lee E  Ohe Y 
Info ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 4, str. S1648-S1649
Projekat Celltrion Inc.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo) (Meeting Abstract)
Autori Kao SCH  Reck M  Liu SV  Dziadziuszko R  Hochmair MJ  Huemer F  Gilberto de Castro J  Bernabe Caro R  Kim SH  Kowalski DM  Andric Zoran G  Oancea M  Kaul M  Li H  Danner B  Lee MC  Nabet BY  Sugawara S 
Info ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 4, str. S1638-S1638
Projekat F. Hoffmann-La Roche, Ltd.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON) (Article)
Autori Tobias Joshua  ...  Andric Zoran G  ...  Nikolic Ivan V  Petrovic Zoran  ...  (broj koautora 17) 
Info CLINICAL CANCER RESEARCH, (2024), vol. 30 br. 18, str. 4044-4054
Projekat Imugene Ltd.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Tumor Treating Fields (TTFields) therapy with standard systemic therapy in metastatic non-small cell lung cancer following progression on or after platinum-based therapy: global, randomized, pivotal (phase 3) LUNAR study (Meeting Abstract)
Autori Greil Richard  ...  Andric Zoran G  ...  (broj koautora 25) 
Info ONCOLOGY RESEARCH AND TREATMENT, (2024), vol. 47 br. , Suppl. 1, str. 131-132
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Five-year survival in patients with ES-SCLC treated with atezolizumab in IMpower133: IMbrella A extension study results (Meeting Abstract)
Autori Schuette Wolfgang  Andric Zoran G  ...  (broj koautora 25) 
Info ONCOLOGY RESEARCH AND TREATMENT, (2024), vol. 47 br. , Suppl. 1, str. 124-125
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON) (Meeting Abstract)
Autori Tobias Joshua  ...  Andric Zoran G  Petrovic Z  Nikolic Ivan V  ...  (broj koautora 17) 
Info ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 2, str. S886-S886
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study (Article)
Autori Reck Martin  ...  Andric Zoran G  ...  (broj koautora 24) 
Info LUNG CANCER, (2024), vol. 196 br. , str. -
Projekat F. Hoffmann-La Roche Ltd.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer (Article)
Autori Spigel David R  ...  Stojanovic Goran  ...  Andric Zoran G  ...  (broj koautora 17) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2024), vol. 42 br. 19, str. -
Projekat Ipsen
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Ispis zapisa u formatu:TXT | BibTeX